Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients

Molecular Oncology

Volumn 7, Issue 1, 2013, Pages 29-40

  Nymark, Penny ^a,b   Aavikko, Mervi ^a   Mäkilä, Jussi ^a   Ruosaari, Salla ^a   Hienonen Kempas, Tuija ^a   Wikman, Harriet ^c   Salmenkivi, Kaisa ^b   Pirinen, Risto ^d   Karjalainen, Antti ^a   Vanhala, Esa ^a   Kuosma, Eeva ^a   Anttila, Sisko ^a,b   Kettunen, Eeva ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Asbestos exposure; Lung cancer; Pulmonary epithelium

Indexed keywords

ASBESTOS;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; ASBESTOSIS; CANCER TISSUE; COPY NUMBER VARIATION; DNA EXTRACTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84872493162     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.07.006     Document Type: Article

References (44)

1. Andersen C.L., Hostetter G., Grigoryan A., Sauter G., Kallioniemi A. Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 2001, 45:83-86.
2. Andujar P., Wang J., Descatha A., Galateau-Sallé F., Abd-Alsamad I., Billon-Galland M.-A., Blons H., Clin B., Danel C., Housset B., Laurent-Puig P., Le Pimpec-Barthes F., Letourneux M., Monnet I., Régnard J.-F., Renier A., Zucman-Rossi J., Pairon J.-C., Jaurand M.-C. p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Canc. 2010, 67:23-30.
3. Anttila S., Raunio H., Hakkola J. Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis. Am. J. Respir. Cell. Mol. Biol. 2011, 44:583-590.
4. Beetz C., Brodoehl S., Patt S., Kalff R., Deufel T. Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma. Oncol. Rep. 2005, 13:335-340.
5. Berry G., Newhouse M.L., Wagner J.C. Mortality from all cancers of asbestos factory workers in east London 1933-80. Occup. Environ. Med. 2000, 57:782-785.
6. Björkqvist A.-M., Tammilehto L., Nordling S., Nurminen M., Anttila S., Mattson K., Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br. J. Cancer 1998, 77:260-269.
7. Cary, N., 2009. SAS OlineDoc ò. In: SAS Institute Inc., SAS Institute Inc.
8. Clin B., Morlais F., Launoy G., Guizard A.V., Dubois B., Bouvier V., Desoubeaux N., Marquignon M.F., Raffaelli C., Paris C., Galateau-Salle F., Guittet L., Letourneux M. Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose-response relationships. Occup. Environ. Med. 2011, 68:832-836.
9. Daskalos A., Oleksiewicz U., Filia A., Nikolaidis G., Xinarianos G., Gosney J.R., Malliri A., Field J.K., Liloglou T. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 2011, 117:1027-1037.
10. Dehan E., Ben-Dor A., Liao W., Lipson D., Frimer H., Rienstein S., Simansky D., Krupsky M., Yaron P., Friedman E., Rechavi G., Perlman M., Aviram-Goldring A., Izraeli S., Bittner M., Yakhini Z., Kaminski N. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Canc. 2007, 56:175-184.
11. Gao S., Worm J., Guldberg P., Eiberg H., Krogdahl A., Sorensen J.A., Liu C.J., Reibel J., Dabelsteen E. Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma. Br. J. Cancer 2004, 91:760-764.
12. Gronbaek K., Ralfkiaer U., Dahl C., Hother C., Burns J.S., Kassem M., Worm J., Ralfkiaer E.M., Knudsen L.M., Hokland P., Guldberg P. Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod. Pathol. 2008, 21:632-638.
13. Gustavsson P., Nyberg F., Pershagen G., Scheele P., Jakobsson R., Plato N. Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden. Am. J. Epidemiol. 2002, 155:1016-1022.
14. Hilbe W., Auberger J., Dirnhofer S., Schmid T., Erdel M., Duba H.C. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation. Oncol. Rep. 2006, 15:1233-1240.
15. Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., Hirohashi S., Inazawa J., Imoto I. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum. Mol. Genet. 2005, 14:997-1007.
16. Jamrozik E., de Klerk N., Musk A.W. Asbestos-related disease. Intern. Med. J. 2011, 41:372-380.
17. Karjalainen A., Anttila S., Heikkilä L., Karhunen P., Vainio H. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am. J. Ind. Med. 1993, 23:461-471.
18. Karjalainen A., Anttila S., Vanhala E., Vainio H. Asbestos exposure and the risk of lung cancer in a general urban population. Scand. J. Work Environ. Health 1994, 20:243-250.
19. Kettunen E., Aavikko M., Nymark P., Ruosaari S., Wikman H., Vanhala E., Salmenkivi K., Pirinen R., Karjalainen A., Kuosma E., Anttila S. DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. Br. J. Cancer 2009, 100:1336-1342.
20. Knudson A. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U S A 1971, 68:820-823.
21. Kraunz K.S., Nelson H.H., Lemos M., Godleski J.J., Wiencke J.K., Kelsey K.T. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer. Int. J. Cancer 2006, 118:1364-1369.
22. LaDou J. The asbestos cancer epidemic. Environ. Health Perspect. 2004, 112:285-290.
23. Lindholm P., Salmenkivi K., Vauhkonen H., Nicholson A., Anttila S., Kinnula V., Knuutila S. Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogenet. Genome Res. 2007, 119:46-52.
24. Marsit C., Hasegawa M., Hirao T., Kim D.-H., Aldape K., Hinds P., Wiencke J., Nelson H., Kelsey K. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Cancer Res. 2004, 64:8702-8707.
25. Massion P.P., Zou Y., Chen H., Jiang A., Coulson P., Amos C.I., Wu X., Wistuba I., Wei Q., Shyr Y., Spitz M.R. Smoking-related genomic signatures in non-small cell lung cancer. Am. J. Respir. Crit. Care Med. 2008, 178:1164-1172.
26. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNAs from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
27. Miserocchi G., Sancini G., Mantegazza F., Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ. Health 2008, 7:4.
28. Nishiyama H., Gill J.H., Pitt E., Kennedy W., Knowles M.A. Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 2001, 20:2956-2964.
29. Nymark P., Guled M., Borze I., Faisal A., Lahti L., Salmenkivi K., Kettunen E., Anttila S., Knuutila S. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Gene. Chromosome Canc. 2011, 50:585-597.
30. Nymark P., Kettunen E., Aavikko M., Ruosaari S., Kuosma E., Vanhala E., Salmenkivi K., Pirinen R., Karjalainen A., Knuutila S., Wikman H., Anttila S. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer. Clin. Cancer Res. 2009, 15:468-475.
31. Nymark P., Wikman H., Ruosaari S., Hollmén J., Vanhala E., Karjalainen A., Anttila S., Knuutila S. Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res. 2006, 16:5737-5743.
32. Rajakumara E., Wang Z., Ma H., Hu L., Chen H., Lin Y., Guo R., Wu F., Li H., Lan F., Shi Y.G., Xu Y., Patel D.J., Shi Y. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol. Cell. 2011, 43:275-284.
33. Ruosaari S., Hienonen-Kempas T., Puustinen A., Sarhadi V., Hollmén J., Knuutila S., Saharinen J., Wikman H., Anttila S. Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients. BMC Med. Genet. 2008, 1:55.
34. Ruosaari S.T., Nymark P.E.H., Aavikko M.M., Kettunen E., Knuutila S., Hollmén J., Norppa H., Anttila S.L. Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro. Carcinogenesis 2008, 29:913-917.
35. Sanchez-Cespedes M., Parrella P., Esteller M., Nomoto S., Trink B., Engles J.M., Westra W.H., Herman J.G., Sidransky D. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 2002, 62:3659-3662.
36. Sanz-Ortega J., Saez M.C., Sierra E., Torres A., Balibrea J.L., Hernando F., Sanz-Esponera J., Merino M.J. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy. J. Pathol. 2001, 195:429-434.
37. Taniguchi T., Karnan S., Fukui T., Yokoyama T., Tagawa H., Yokoi K., Ueda Y., Mitsudomi T., Horio Y., Hida T., Yatabe Y., Seto M., Sekido Y. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. Cancer Sci. 2007, 98:438-446.
38. Unoki M., Daigo Y., Koinuma J., Tsuchiya E., Hamamoto R., Nakamura Y. UHRF1 is a novel diagnostic marker of lung cancer. Br. J. Cancer 2010, 103:217-222.
39. Wikman H., Ruosaari S., Nymark P., Sarhadi V.K., Saharinen J., Vanhala E., Karjalainen A., Hollmén J., Knuutila S., Anttila S. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 2007, 26:4730-4737.
40. Wistuba, Lam S., Behrens C., Virmani A.K., Fong K.M., LeRiche J., Samet J.M., Srivastava S., Minna J.D., Gazdar A.F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 1997, 89:1366-1373.
41. Wistuba I., Mao L., Gazdar A. Smoking molecular damage in bronchial epithelium. Oncogene 2002, 21:7298-7306.
42. Wright C.M., Larsen J.E., Hayward N.K., Martins M.U., Tan M.E., Davidson M.R., Savarimuthu S.M., McLachlan R.E., Passmore L.H., Windsor M.N., Clarke B.E., Duhig E.E., Yang I.A., Bowman R.V., Fong K.M. ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas. Gene. Chromosome Canc. 2010, 49:688-698.
43. Yanagisawa K., Konishi H., Arima C., Tomida S., Takeuchi T., Shimada Y., Yatabe Y., Mitsudomi T., Osada H., Takahashi T. Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways. Cancer Res. 2010, 70:9949-9958.
44. Zhang Y., Wang R., Song H., Huang G., Yi J., Zheng Y., Wang J., Chen L. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett. 2011, 303:21-28.